NBCA is honored to announce MyMichigan Medical Center Midland as the first hospital in the U.S. to be designated a Deep Vein Thrombosis (DVT) Center of Excellence.™
This designation highlights MyMichigan’s dedication to delivering cutting-edge, patient-centered DVT care and advancing national standards in venous thromboembolism (VTE) management.
By integrating evidence-based practices, multidisciplinary coordination, and a strong emphasis on early detection and follow-up, MyMichigan Medical Center Midland has established a DVT program that serves as a benchmark for excellence.
“We’re proud of the work being done here in Midland to make DVT care more proactive, coordinated, and effective,” said Jacob Frisbie, M.D., MyMichigan vascular surgeon and physician VTE champion. “This designation validates our team’s focus on making sure patients receive timely intervention, the right treatment, and the long-term support they need to recover and thrive.”
NBCA’s DVT Center of Excellence (COE) ™ program identifies and supports hospitals that go beyond standard care protocols, demonstrating exceptional leadership, quality, and innovation in clot-related care. Designated centers also serve as collaborators in national education and advocacy efforts aimed at reducing the burden of blood clots.
In its role as the inaugural DVT COE, MyMichigan will work alongside NBCA as well as existing and future designated centers to drive innovation, share best practices, and promote awareness about VTE prevention and treatment nationwide.
They join distinguished institutions such as Corewell Health West Butterworth Hospital in Grand Rapids, MI, Ascension Sacred Heart Hospital in Pensacola, FL, and AdventHealth Palm Coast and Palm Coast Parkway Hospitals in Palm Coast, FL as leaders in the VTE space.
Learn more about NBCA’s VTE Center of Excellence™ program here.
